Drugs News and Research

RSS

Understanding the particle drifting effect with Dr. Na Li

Join Dr. Na Li as she explores the mysteries of the particle drifting effect and its practical applications in real-world scenarios.

From Pion Inc 5 May 2025

Advancing benzodiazepine detection for toxicology

Learn how experts are advancing benzodiazepine analysis and detection using insights from the lab.

From Waters Advanced Diagnostics 5 May 2025

Ultra-processed foods linked to higher psoriasis risk

A large UK Biobank study found that higher consumption of ultra-processed foods (UPFs) is associated with an increased risk of developing psoriasis. Each 10% increase in UPF intake raised psoriasis risk by 6%, with obesity and inflammation partially mediating this effect.

4 May 2025

National initiative boosts heart failure treatment across US hospitals

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.

3 May 2025

Rising antibiotic resistance threatens UTI treatment in Malawi

A growing resistance to antibiotics is complicating the treatment of urinary tract infections (UTIs) in Malawi, with new research revealing that nearly half of women presenting with symptoms at a major referral hospital had infections resistant to multiple drugs.

3 May 2025

Study uses artificial intelligence to classify patient pain archetypes after knee replacement

A study using artificial intelligence to classify patient pain archetypes and identify risk for severe pain after knee replacement has earned a Best of Meeting award at the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine.

2 May 2025

New drug technique targets gut inflammation with precision

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.

2 May 2025

Study uncovers 'cell of origin' of the second most common lung cancer

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the Wellcome Sanger Institute and the University of Cambridge.

2 May 2025

Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today.

1 May 2025

New antibody design enhances immune system's ability to fight cancer

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

1 May 2025

Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a severe condition that leads to muscle weakness and premature death.

30 Apr 2025

New protein target offers hope for treating high blood pressure and aortic aneurysms

Oxidative stress can occur when our cells are exposed to harmful molecules called "reactive oxygen species" over time. These reactive oxygen species can damage cells and are found in important disease states, such as high blood pressure and aortic aneurysms.

30 Apr 2025

Machine learning provide new insights into how the brain responds to heroin use

Object recognition software is used by law enforcement to help identify suspects, by self-driving cars to navigate roadways and by many consumers to unlock their cell phones or pay for their morning coffee.

30 Apr 2025

Leveraging the Radian ASAP in standard casework

Explore how the Radian ASAP mass spectrometer is being used to streamline and enhance seized drug screening.

From Waters Advanced Diagnostics 30 Apr 2025

Financial Toxicity Tumor Board approach provides relief from cancer treatment costs

Financial toxicity, the financial distress linked to cancer treatment, significantly impacts patient outcomes. To combat this, the Atrium Health Levine Cancer Institute established a Financial Toxicity Tumor Board in 2019.

29 Apr 2025

HonorHealth unveils first study from new Phoenix lab targeting pancreatic cancer

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new treatment for pancreatic cancer, one of the most aggressive and difficult to treat of all malignancies.

29 Apr 2025

HonorHealth Research Institute treats first patient in global trial targeting aggressive melanoma

HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of skin cancer.

29 Apr 2025

New compounds identified as inhibitors of DNA topoisomerase 1

Andrés Aguilera's laboratory, in collaboration with that of Ralf Wellinger (both professors in the Department of Genetics at the University of Seville in CABIMER) and with PharmaMAR, has identified two natural compounds, patulin and xestoquinol, as new inhibitors of the enzyme topoisomerase 1, a key element in the correct functioning of DNA.

29 Apr 2025

$Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma$

Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30), which has shown high efficacy in patients with refractory CD30+ lymphoma.

29 Apr 2025

Researchers uncover how substance use accelerates brain aging

In a comprehensive Genomic Press Interview, researchers from UTHealth Houston have uncovered crucial evidence that substance use disorders (SUDs) accelerate biological aging in the brain through distinct molecular mechanisms.

29 Apr 2025

Drugs News and Research

Understanding the particle drifting effect with Dr. Na Li

Advancing benzodiazepine detection for toxicology

Ultra-processed foods linked to higher psoriasis risk

National initiative boosts heart failure treatment across US hospitals

Rising antibiotic resistance threatens UTI treatment in Malawi

Study uses artificial intelligence to classify patient pain archetypes after knee replacement

New drug technique targets gut inflammation with precision

Study uncovers 'cell of origin' of the second most common lung cancer

Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment

New antibody design enhances immune system's ability to fight cancer

Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy

New protein target offers hope for treating high blood pressure and aortic aneurysms

Machine learning provide new insights into how the brain responds to heroin use

Leveraging the Radian ASAP in standard casework

Financial Toxicity Tumor Board approach provides relief from cancer treatment costs

HonorHealth unveils first study from new Phoenix lab targeting pancreatic cancer

HonorHealth Research Institute treats first patient in global trial targeting aggressive melanoma

New compounds identified as inhibitors of DNA topoisomerase 1

Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma

Researchers uncover how substance use accelerates brain aging

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News